178 related articles for article (PubMed ID: 38105176)
1. Direct letters to relatives at risk of hereditary cancer-study protocol for a multi-center randomized controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study).
Hawranek C; Ehrencrona H; Öfverholm A; Hellquist BN; Rosén A
Trials; 2023 Dec; 24(1):810. PubMed ID: 38105176
[TBL] [Abstract][Full Text] [Related]
2. Facilitated cascade testing (FaCT): a randomized controlled trial.
Nitecki R; Moss HA; Watson CH; Urbauer DL; Melamed A; Lu KH; Lipkin SM; Offit K; Rauh-Hain JA; Frey MK
Int J Gynecol Cancer; 2021 May; 31(5):779-783. PubMed ID: 33443030
[TBL] [Abstract][Full Text] [Related]
3. Proband-mediated interventions to increase disclosure of genetic risk in families with a BRCA or Lynch syndrome condition: a systematic review.
Young AL; Imran A; Spoelma MJ; Williams R; Tucker KM; Halliday J; Forrest LE; Wakefield CE; Butow PN
Eur J Hum Genet; 2023 Jan; 31(1):18-34. PubMed ID: 36253533
[TBL] [Abstract][Full Text] [Related]
4. Informing relatives about their hereditary or familial cancer risk: study protocol for a randomized controlled trial.
de Geus E; Aalfs CM; Verdam MG; de Haes HC; Smets EM
Trials; 2014 Mar; 15():86. PubMed ID: 24649895
[TBL] [Abstract][Full Text] [Related]
5. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
6. The experience of receiving a letter from a cancer genetics clinic about risk for hereditary cancer.
Öfverholm A; Karlsson P; Rosén A
Eur J Hum Genet; 2024 May; 32(5):539-544. PubMed ID: 38355958
[TBL] [Abstract][Full Text] [Related]
7. Risk of Syndrome-Associated Cancers Among First-Degree Relatives of Patients With Pancreatic Ductal Adenocarcinoma With Pathogenic or Likely Pathogenic Germline Variants.
Chen X; Meyer MA; Kemppainen JL; Horibe M; Chandra S; Majumder S; Petersen GM; Rabe KG
JAMA Oncol; 2023 Jul; 9(7):955-961. PubMed ID: 37200008
[TBL] [Abstract][Full Text] [Related]
8. Patients' perceptions and practices of informing relatives: a qualitative study within a randomised trial on healthcare-assisted risk disclosure.
Nääs C; von Salomé J; Rosén A
Eur J Hum Genet; 2024 Apr; 32(4):448-455. PubMed ID: 38308085
[TBL] [Abstract][Full Text] [Related]
9. The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice.
Menko FH; Ter Stege JA; van der Kolk LE; Jeanson KN; Schats W; Moha DA; Bleiker EMA
Fam Cancer; 2019 Jan; 18(1):127-135. PubMed ID: 29846880
[TBL] [Abstract][Full Text] [Related]
10. Improving family communication after a new genetic diagnosis: a randomised controlled trial of a genetic counselling intervention.
Hodgson JM; Metcalfe SA; Aitken M; Donath SM; Gaff CL; Winship IM; Delatycki MB; Skene LL; McClaren BJ; Paul JL; Halliday JL
BMC Med Genet; 2014 Mar; 15():33. PubMed ID: 24628824
[TBL] [Abstract][Full Text] [Related]
11. A tailored approach towards informing relatives at risk of inherited cardiac conditions: study protocol for a randomised controlled trial.
van den Heuvel LM; Hoedemaekers YM; Baas AF; van Tintelen JP; Smets EMA; Christiaans I
BMJ Open; 2019 Jul; 9(7):e025660. PubMed ID: 31289060
[TBL] [Abstract][Full Text] [Related]
12. IMProving care After inherited Cancer Testing (IMPACT) study: protocol of a randomized trial evaluating the efficacy of two interventions designed to improve cancer risk management and family communication of genetic test results.
Cragun D; Beckstead J; Farmer M; Hooker G; Dean M; Matloff E; Reid S; Tezak A; Weidner A; Whisenant JG; Pal T
BMC Cancer; 2021 Oct; 21(1):1099. PubMed ID: 34645413
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
14. Psychosocial and clinical factors of probands impacting intrafamilial disclosure and uptake of genetic testing among families with BRCA1/2 or MMR gene mutations.
Alegre N; Perre PV; Bignon YJ; Michel A; Galibert V; Mophawe O; Corsini C; Coupier I; Chiesa J; Robert L; Bernhard L; Picot MC; Bertet H; Macioce V; Bastide N; Solassol J; Rey JM; Thomas F; Carton S; Pujol P
Psychooncology; 2019 Aug; 28(8):1679-1686. PubMed ID: 31152683
[TBL] [Abstract][Full Text] [Related]
15. Sharing genetic test results in Lynch syndrome: communication with close and distant relatives.
Stoffel EM; Ford B; Mercado RC; Punglia D; Kohlmann W; Conrad P; Blanco A; Shannon KM; Powell M; Gruber SB; Terdiman J; Chung DC; Syngal S
Clin Gastroenterol Hepatol; 2008 Mar; 6(3):333-8. PubMed ID: 18258490
[TBL] [Abstract][Full Text] [Related]
16. Uptake of predictive testing among relatives of BRCA1 and BRCA2 families: a multicenter study in northeastern Spain.
Sanz J; Ramón y Cajal T; Torres A; Darder E; Gadea N; Velasco A; Fortuny D; López C; Fisas D; Brunet J; Alonso MC; Balmaña J
Fam Cancer; 2010 Sep; 9(3):297-304. PubMed ID: 20091130
[TBL] [Abstract][Full Text] [Related]
17. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
18. Communication about positive BRCA1 and BRCA2 genetic test results and uptake of testing in relatives in a diverse Asian setting.
Lee DS; Meiser B; Mariapun S; Hassan T; Yip CH; Mohd Taib NA; Teo SH; Thong MK; Yoon SY
J Genet Couns; 2021 Jun; 30(3):720-729. PubMed ID: 33245177
[TBL] [Abstract][Full Text] [Related]
19. Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol.
Katapodi MC; Viassolo V; Caiata-Zufferey M; Nikolaidis C; Bührer-Landolt R; Buerki N; Graffeo R; Horváth HC; Kurzeder C; Rabaglio M; Scharfe M; Urech C; Erlanger TE; Probst-Hensch N; Heinimann K; Heinzelmann-Schwarz V; Pagani O; Chappuis PO
JMIR Res Protoc; 2017 Sep; 6(9):e184. PubMed ID: 28931501
[TBL] [Abstract][Full Text] [Related]
20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]